197 Results

People

  1. Ladanyi
    Ladanyi
  2. Kris
    Kris
  3. Riely
    Riely
  4. Solit
    Solit
  5. Arcila
    Arcila
  6. O'Reilly
    O'Reilly
  7. Rusch
    Rusch
  8. Schultz
    Schultz
  9. Basturk
    Basturk
  10. Shia
    Shia

Groups

  1. Department of Medicine (115)
  2. Solid Tumor Oncology Division (105)
  3. GSK Faculty (92)
  4. Department of Pathology and Laboratory Medicine (77)
  5. Human Oncology and Pathogenesis Program (66)
  6. Surgery (54)
  7. Center for Pancreatic Cancer Research (49)
  8. Thoracic Oncology (47)
  9. Gastrointestinal Oncology Service (43)
  10. Tow Center for Developmental Oncology (TCDO) (43)
  1. "k ras protein"
Formats
  1. Journal Article (182)
  2. Review (10)
  3. Editorial (4)
  4. Conference Paper (1)
Groups
  1. Department of Medicine (115)
  2. Solid Tumor Oncology Division (105)
  3. GSK Faculty (92)
  4. Department of Pathology and Laboratory Medicine (77)
  5. Human Oncology and Pathogenesis Program (66)
  6. Surgery (54)

More Groups

People
  1. Marc Ladanyi (32)
  2. Mark Kris (24)
  3. Gregory Riely (21)
  4. David Solit (16)
  5. Maria Arcila (13)
  6. Maureen Zakowski (13)

More People

Years
  1. 2025 (14)
  2. 2024 (23)
  3. 2023 (11)
  4. 2022 (6)
  5. 2021 (4)
  6. 2020 (14)

More Years

Publications
  1. Clinical Cancer Research (12)
  2. Journal of Thoracic Oncology (10)
  3. Proceedings of the National Academy of Sciences of the United States of America (8)
  4. Cancer Cell (7)
  5. Modern Pathology (7)
  6. Journal of Clinical Oncology (6)

More Publications

Publishers
  1. Elsevier Inc. (31)
  2. American Association for Cancer Research (24)
  3. Cell Press (14)
  4. Wiley Blackwell (14)
  5. Nature Publishing Group (13)
  6. Lippincott Williams & Wilkins (12)

More Publishers

Results (197)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • RAS mutations in cutaneous squamous-cell carcinomas in patients treated with BRAF inhibitors
    Journal Article

    Su, F.; Viros, A.; Milagre, C.; Trunzer, K.; Bollag, G.; Spleiss, O.; Reis-Filho, J. S.; Kong, X.; Koya, R. C.; Flaherty, K. T.; more...
    New England Journal of Medicine (2012)

    Fulltext@MSK | Save
  • Genomics and pharmacogenomics of pancreatic adenocarcinoma
    Journal Article

    Lowery, M. A.; O'Reilly, E. M.
    Pharmacogenomics Journal (2012)

    Fulltext@MSK | Save
  • Self-renewal does not predict tumor growth potential in mouse models of high-grade glioma
    Journal Article

    Barrett, L. E.; Granot, Z.; Coker, C.; Iavarone, A.; Hambardzumyan, D.; Holland, E. C.; Nam, H. S.; Benezra, R.
    Cancer Cell (2012)

    Fulltext@MSK | Save
  • Resistance to EGFR inhibitors: Molecular determinants and the enigma of head and neck cancer
    Journal Article

    Morris, L. G. T.; Chan, T. A.
    Oncotarget (2011)

    Fulltext@MSK | Save
  • Gastrointestinal cancer educational case series: Management of metastatic adenocarcinoma of unknown primary origin in a Ph+ ALL survivor
    Journal Article

    Ang, C.; O'Reilly, E. M.; Abou-Alfa, G. K.; Shamseddine, A.; Skouri, H.; Tawil, A.; Eloubeidi, M. A.; Lowery, M.; Kharfan-Dabaja, M.; Kaprealian, T.; more...
    Journal of Gastrointestinal Cancer (2011)

    Fulltext@MSK | Save
  • The future role of the gastroenterologist in digestive oncology: An international perspective
    Journal Article

    Winawer, S. J.; Pasricha, P. J.; Schmiegel, W.; Sinicrope, F. A.; Sung, J.; Seufferlein, T.; Kassem, A. M.; Malekzadeh, R.; Kurtz, R. C.; Classen, M.; more...
    Gastroenterology (2011)

    Fulltext@MSK | Save
  • Superoxide dismutase 1 (SOD1) is a target for a small molecule identified in a screen for inhibitors of the growth of lung adenocarcinoma cell lines
    Journal Article

    Somwar, R.; Erdjument-Bromage, H.; Larsson, E.; Shum, D.; Lockwood, W. W.; Yang, G.; Sander, C.; Ouerfelli, O.; Tempst, P. J.; Djaballah, H.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2011)

    Fulltext@MSK | Save
  • A phase II trial of salirasib in patients with lung adenocarcinomas with KRAS mutations
    Journal Article

    Riely, G. J.; Johnson, M. L.; Medina, C.; Rizvi, N. A.; Miller, V. A.; Kris, M. G.; Pietanza, M. C.; Azzoli, C. G.; Krug, L. M.; Pao, W.; more...
    Journal of Thoracic Oncology (2011)

    Fulltext@MSK | Save
  • KRAS and colorectal cancer: Ethical and pragmatic issues in effecting real-time change in oncology clinical trials and practice
    Journal Article

    Blanke, C. D.; Goldberg, R. M.; Grothey, A.; Mooney, M.; Roach, N.; Saltz, L. B.; John, J. W.; William, A. W.; Meropol, N. J.
    The Oncologist (2011)

    Fulltext@MSK | Save
  • Targeting mutated K-ras in pancreatic adenocarcinoma using an adjuvant vaccine
    Journal Article

    Abou-Alfa, G. K.; Chapman, P. B.; Feilchenfeldt, J.; Brennan, M. F.; Capanu, M.; Gansukh, B.; Jacobs, G.; Levin, A.; Neville, D.; Kelsen, D. P.; more...
    American Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save